MDNC (Medinotec) EBITDA Margin %: -11.36% (As of Feb. 2026)

What is Medinotec EBITDA Margin %?

Medinotec MDNC 24 EBITDA Margin % is -11.36% as of Feb. 2026. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medinotec's EBITDA for the three months ended in Feb. 2026 was $-0.21 Mil. Medinotec's Revenue for the three months ended in Feb. 2026 was $1.82 Mil. Therefore, Medinotec's EBITDA margin for the quarter that ended in Feb. 2026 was -11.36%.

Medinotec (OTCPK:MDNC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medinotec EBITDA Margin % Related Terms

Medinotec EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medinotec's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinotec EBITDA Margin % Chart

Medinotec Annual Data

Trend

Feb22

Feb23

Feb24

Feb25

Feb26

EBITDA Margin %

0.00

-11.10

2.23

35.92

12.72

Medinotec Quarterly Data
	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
EBITDA Margin %	Get a 7-Day Free Trial													55.86	14.15	18.08	21.96	-11.36

MDNC vs NVNO, APYX, RDGL: EBITDA Margin % Comparison

For the Medical Devices subindustry, Medinotec's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medinotec EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medinotec's EBITDA Margin % falls into.

Save Embed

24GF Score

Medinotec Inc MDNC

EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medinotec EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medinotec's EBITDA Margin % for the fiscal year that ended in Feb. 2026 is calculated as

EBITDA Margin %	=	EBITDA (A: Feb. 2026 )	/	Revenue (A: Feb. 2026 )
	=	1.238	/	9.729
	=	12.72 %

Medinotec's EBITDA Margin % for the quarter that ended in Feb. 2026 is calculated as

EBITDA Margin %	=	EBITDA (Q: Feb. 2026 )	/	Revenue (Q: Feb. 2026 )
	=	-0.207	/	1.822
	=	-11.36 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -11.36% mean?

Medinotec (MDNC) has a EBITDA Margin % of -11.36% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medinotec and its competitors.

Is Medinotec's EBITDA Margin % too high?

Medinotec's current EBITDA Margin % is -11.36%. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.

How does Medinotec's EBITDA Margin % compare to NVNO and APYX?

Medinotec's EBITDA Margin % of -11.36% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Medical Devices & Instruments company?

The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current EBITDA Margin % is -11.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medinotec stock overvalued right now?

Medinotec (MDNC) has a current EBITDA Margin % of -11.36%. The current EBITDA Margin % is -11.36%. Medinotec's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Medinotec (MDNC), the current EBITDA Margin % is -11.36% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medinotec Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies NVNO APYX RDGL TELA ICCM VNRX CTSO SERA OPGN ELUT ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD

Address Stand 299 Avant Garde Avenue, 10 New Market Street, Northlands Deco Park, North Riding, Johannesburg, GT, ZAF, 2169

Website https://www.medinotecinc.com

Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.

24GF Score

Get the complete analysis for MDNC

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.00

Price

View MDNC Analysis

See EBITDA Margin % data for all stocks →